This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Murchinson Objects to Nano...
Business shareholder dispute

Murchinson Objects to Nano Dimension-Infinite Deal

Analysis based on 6 articles · First reported Jun 15, 2026 · Last updated Jun 15, 2026

Sentiment
-50
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is likely to react negatively to Nano Dimension Ltd.'s stock due to the uncertainty and potential value destruction highlighted by Murchinson's opposition to the Infinite Epigenetics transaction. This shareholder dispute could lead to increased volatility for Nano Dimension Ltd. and potentially impact investor confidence in its management.

Asset Management 3D Printing Biotechnology
Event Summary

Murchinson, a significant shareholder of Nano Dimension Ltd., has publicly criticized Nano Dimension Ltd.'s Board of Directors for signing a non-binding term sheet with Infinite Epigenetics to form a new publicly traded, AI-powered health and diagnostics company. Murchinson views this proposed transaction as a poor business decision, inconsistent with Nano Dimension Ltd.'s stated business model, and potentially value-destructive. They also raised concerns about the lack of transparency from Nano Dimension Ltd.'s Board and the involvement of Michael X. Garrett, who was on the Board during the allegedly value-destroying Desktop Metal acquisition. Murchinson intends to continue objecting to what it perceives as speculative and entrenchment-driven initiatives.

Entities Involved
stock
Nano Dimension
Nano Dimension is the company whose Board of Directors is proposing a transaction with Infinite Epigenetics, which Murchinson is strongly opposing. The company's strategic direction and shareholder value are at stake due to this proposed deal and the ongoing shareholder dispute.
Importance 100.0 Sentiment -60.0
priv
Murchinson
Murchinson is a significant shareholder of Nano Dimension Ltd. and is actively objecting to the proposed transaction with Infinite Epigenetics, believing it to be value-destructive and a misallocation of corporate resources. Its actions aim to protect its investment and influence Nano Dimension Ltd.'s strategic direction.
Importance 90.0 Sentiment 70.0
oth
Infinite Epigenetics
Infinite Epigenetics is the target of a proposed non-binding term sheet with Nano Dimension Ltd. to form a new publicly traded company. The transaction is controversial and faces strong opposition from a major Nano Dimension Ltd. shareholder, Murchinson
Importance 80.0 Sentiment -30.0
per
David Stehlin
David Stehlin is the CEO of Nano Dimension Ltd. and is criticized by Murchinson for his lack of transparency and for referencing 'strategic flexibility' in justifying the proposed transaction with Infinite Epigenetics.
Importance 60.0 Sentiment -40.0
per
Michael X. Garrett
Michael X. Garrett is an advisor to Infinite Epigenetics and previously served on Nano Dimension Ltd.'s Board when the Desktop Metal acquisition was approved, an acquisition Murchinson views as value-destructive. His involvement raises concerns for Murchinson regarding the current proposed transaction.
Importance 50.0 Sentiment -40.0
stock
Desktop Metal
Desktop Metal was acquired by Nano Dimension Ltd. in a deal that Murchinson claims destroyed hundreds of millions of dollars of Nano Dimension Ltd.'s capital. This past acquisition is cited by Murchinson as a reason to distrust the current Board's decision-making.
Importance 30.0 Sentiment -20.0
per
Yoav Stern
Yoav Stern was the previous CEO of Nano Dimension Ltd. under whose Board Murchinson claims similar issues with transparency and decision-making occurred, drawing a parallel to the current Board's actions.
Importance 20.0 Sentiment -30.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.